Bausch Health Companies Inc. Common Stock (BHC)
R&D Expense Growth
-0.79%
Fiscal year · Period ending:
BHC R&D Expense Growth
Latest reported-0.79%period ending
Latest reported-0.79%period ending
BHC FY R&D Growth (YoY) (0.00% → -0.79%)
Latest values, visible window
High-resolution chart · PNG
BHC r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -0.7886% | |
| 4.9669% | |
| 13.9623% | |
| 12.0507% | |
| -2.4742% | |
| -6.0078% | |
| 16.7421% | |
| 19.7832% | |
| -21.322% | |
| 6.5909% | |
| 65.4135% | |
| 69.6429% | |
| 98.2301% | |
| -54.7708% | |
| 10.9999% | |
| 1,013.6274% | |
| -84.7615% | |
| -21.3966% | |
| 23.7164% | |
| 7.4142% | |
| 22.5986% | |
| -16.2527% | |
| 66.0019% | |
| 2.2208% | |
| -3.1182% | |
| 59.0906% | |
| 89.1429% | |
| 0% | |
| -100% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |